Item 7.01. Regulation FD Disclosure.

Earlier today, the United States Department of Justice filed a complaint against Walmart Inc. ("Walmart") regarding the dispensing and distribution of opioids in the United States. A copy of the Corporate Statement issued by Walmart in response to the complaint is furnished as Exhibit 99.1 to this report.

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise be subject to the liability of that section and shall not be incorporated by reference into any filing or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing or document.




Item 9.01. Financial Statements and Exhibits.
(d)  Exhibits
99.1         Walmart Corporate Statement dated December 22, 2020 issued by Walmart Inc.
           related to a complaint filed by the United States Department of Justice.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses